FAAH and post-traumatic stress disorder: There is currently an ongoing trial with this FAAH inhibitor for PTSD (clinical trial EudraCT 2020-001965-36), as well as a large multi-site trial for PTSD with PF-04457845 (now called JZP150 since acquisition of this compound by Jazz Pharmaceuticals; clinical trial NCT05178316).